From “Treat to Target” to Tailored Treatment: Leveraging Clinical Insights with Eli Lilly’s Novel Therapies to Personalize Obesity Care

Time: 10:00 am
day: Day Two

Details:

  • Implementing a “Treat to Target” strategy allows clinicians to use data-driven insights for personalization, which results in more effective and proactive patient care
  • Leveraging next-generation therapies from Eli Lilly provides new opportunities to reach specific treatment goals for individual patients, ultimately leading to clinically meaningful and sustained health improvements
  • This paradigm shift in obesity management fosters a continuous feedback loop, which optimizes therapeutic outcomes, resulting in better patient adherence and long-term success

Speakers: